We sought to determine if the observed alterations in BDP1 in serous ovarian cancer are unique to BDP1 (Figure 1) or are a common feature in all TFIIIB subunits including, BRF1, BRF2, and TBP which have been previously shown to be deregulated in cancer. This evidence concerns the gene BRF1 and ovarian serous adenocarcinoma.